Search Results - HORMONE receptors

1

Academic Journal

Tracking conformational transitions of the gonadotropin hormone receptors in a bilayer of (SDPC) poly-unsaturated lipids from all-atom molecular dynamics simulations.

Authors: Jardón-Valadez, Eduardo¹ (AUTHOR) h.jardon@correo.ler.uam.mx, Ulloa-Aguirre, Alfredo^2,3 (AUTHOR) h.jardon@correo.ler.uam.mx

Superior Title: PLoS Computational Biology. 1/11/2024, Vol. 20 Issue 1, p1-24. 24p.

Subject Terms: *BILAYER lipid membranes, *HORMONE receptors, *MOLECULAR dynamics, *G protein coupled receptors, *LUTEINIZING hormone receptors, *MOLECULAR structure, *GONADOTROPIN, *THYROTROPIN receptors

HTML Full Text PDF Full Text

2

Academic Journal

Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications.

Authors: Xu, Shiliang¹ (AUTHOR), Wang, Lingxia¹ (AUTHOR), Zhao, Yuexin¹ (AUTHOR), Mo, Tong¹ (AUTHOR), Wang, Bo² (AUTHOR), Lin, Jun¹ (AUTHOR) linjunfey@sina.com, Yang, Huan¹ (AUTHOR) zjyhcherry@126.com

Superior Title: Journal of Biomedical Science. 2/26/2024, Vol. 31 Issue 1, p1-22. 22p.

Subject Terms: *NON-coding RNA, *HORMONE receptor positive breast cancer, *BREAST cancer, *RNA metabolism, *CLINICAL medicine, *ENERGY metabolism

HTML Full Text PDF Full Text

3

Academic Journal

Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer.

Authors: Wang, Wei^1,2 (AUTHOR), Lei, Wenqian³ (AUTHOR), Fang, Ziru¹ (AUTHOR), Jiang, Ruiyuan¹ (AUTHOR), Wang, Xiaojia^1,2 (AUTHOR) wxiaojia0803@163.com

Superior Title: BMC Cancer. 1/2/2024, Vol. 24 Issue 1, p1-13. 13p.

Subject Terms: *METASTATIC breast cancer, *HORMONE receptor positive breast cancer, *PREDICTION models, *RECEIVER operating characteristic curves, *PROGNOSTIC models, *LIVER metastasis

Geographic Terms: ZHEJIANG Sheng (China), CHINA

HTML Full Text PDF Full Text

4

Academic Journal

The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis.

Authors: Huang, Xiewei^1,2 (AUTHOR), Yu, Yushuai^1,2 (AUTHOR), Luo, Shiping^1,2 (AUTHOR), Fu, Wenfen^1,2 (AUTHOR), Zhang, Jie^1,2,3 (AUTHOR) zjie1979@gmail.com, Song, Chuangui^1,2,3 (AUTHOR) Songcg1971@hotmail.com

Superior Title: BMC Cancer. 1/2/2024, Vol. 24 Issue 1, p1-10. 10p.

Subject Terms: *HORMONE receptor positive breast cancer, *METASTATIC breast cancer, *HORMONE therapy, *ESTROGEN receptors, *FIXED effects model, *EPIDERMAL growth factor receptors

HTML Full Text PDF Full Text

5

Academic Journal

DJ-1: A Potential Biomarker Related to Prognosis, Chemoresistance, and Expression of Microenvironmental Chemokine in HR-Positive Breast Cancer.

Authors: Xie, Yinghong¹ (AUTHOR), Li, Yuancheng² (AUTHOR), Yang, Mengzhu^3,4 (AUTHOR)

Superior Title: Journal of Immunology Research. 12/13/2023, p1-15. 15p.

Subject Terms: *HORMONE receptor positive breast cancer, *BIOMARKERS, *BREAST cancer, *PROGNOSIS, *DRUG resistance in cancer cells, *HORMONE receptors

HTML Full Text PDF Full Text

6

Academic Journal

Optimization of supraclavicular lymph node clinical target volume delineation in high-risk breast cancer: a single center experience and recommendation.

Authors: Li, Li^1,2,3 (AUTHOR), Zhang, Hongyan^1,2,3 (AUTHOR), Wang, Linwei^1,2,3 (AUTHOR), Xie, Conghua^1,2,3 (AUTHOR), Yu, Haijun^1,2,3 (AUTHOR) haijunyu@whu.edu.cn, Zhong, Yahua^1,2,3 (AUTHOR) doctorzyh73@163.com

Superior Title: BMC Cancer. 11/29/2023, Vol. 23 Issue 1, p1-7. 7p.

Subject Terms: *HORMONE receptor positive breast cancer, *LYMPH nodes, *BREAST cancer, *LYMPH node cancer, *WATERSHEDS, *LYMPHATIC metastasis

HTML Full Text PDF Full Text

7

Academic Journal

Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling.

Authors: Li, Chaohao¹ (AUTHOR), Allison, Derek B.^2,3 (AUTHOR), He, Daheng³ (AUTHOR), Mao, Fengyi¹ (AUTHOR), Wang, Xinyi¹ (AUTHOR), Rychahou, Piotr^3,4 (AUTHOR), Imam, Ibrahim A.⁵ (AUTHOR), Kong, Yifan¹ (AUTHOR), Zhang, Qiongsi¹ (AUTHOR), Zhang, Yanquan¹ (AUTHOR), Liu, Jinghui¹ (AUTHOR), Wang, Ruixin¹ (AUTHOR), Rao, Xiongjian¹ (AUTHOR), Wu, Sai¹ (AUTHOR), Evers, B. Mark^3,4 (AUTHOR), Shao, Qing⁵ (AUTHOR), Wang, Chi^3,6 (AUTHOR), Li, Zhiguo¹ (AUTHOR), Liu, Xiaoqi^1,3 (AUTHOR) xiaoqi.liu@uky.edu

Superior Title: PLoS Genetics. 11/21/2023, Vol. 19 Issue 11, p1-27. 27p.

Subject Terms: *THYROID hormone receptors, *ARYL hydrocarbon receptors, *ONCOGENES, *METASTASIS, *EPITHELIAL-mesenchymal transition, *LUNG cancer, *CANCER patients

HTML Full Text PDF Full Text

8

Academic Journal

Impact of the OncotypeDX score and HER2 RNA PCR levels on HER2-low IHC levels in primary and metastasized tumors.

Authors: Feldman, Didi¹ (AUTHOR), Sinberger, Liat Anabel² (AUTHOR), Salmon-Divon, Mali^2,3 (AUTHOR), Ben-Dror, Judith⁴ (AUTHOR), Shachar, Shlomit Strulov^4,5 (AUTHOR), Sonnenblick, Amir^4,5 (AUTHOR) amirson@tlvmc.gov.il

Superior Title: BMC Cancer. 10/24/2023, Vol. 23 Issue 1, p1-10. 10p.

Subject Terms: *HORMONE receptor positive breast cancer, *ESTROGEN receptors, *RNA, *TUMORS, *REVERSE transcriptase polymerase chain reaction, *TRASTUZUMAB

HTML Full Text PDF Full Text

9

Academic Journal

Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method.

Authors: Parikh, Purvish¹ (AUTHOR) purvish1@gmail.com, Babu, Govind² (AUTHOR), Singh, Randeep³ (AUTHOR), Krishna, Vamshi⁴ (AUTHOR), Bhatt, Amit⁵ (AUTHOR), Bansal, Indu³ (AUTHOR), Rajappa, Senthil⁶ (AUTHOR), Sahoo, Tarini Prasad⁷ (AUTHOR), Aggarwal, Shyam⁸ (AUTHOR), Bapna, Ajay⁹ (AUTHOR), Biswas, Ghanshyam¹⁰ (AUTHOR), Somashekhar, SP¹¹ (AUTHOR), Bajpai, Jyoti¹² (AUTHOR), Maniar, Vashishtha¹³ (AUTHOR), Desai, Sharad¹⁴ (AUTHOR), Raja, T¹⁵ (AUTHOR), Rath, Goura Kishor¹⁶ (AUTHOR)

Superior Title: BMC Cancer. 7/18/2023, Vol. 23 Issue 1, p1-11. 11p.

Subject Terms: *HORMONE receptor positive breast cancer, *DELPHI method, *BREAST cancer, *INDIAN women (Asians), *ASIANS, *HORMONE receptors

Geographic Terms: INDIA

HTML Full Text PDF Full Text

10

Academic Journal

3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.

Authors: Pérez-García, José Manuel^1,2 (AUTHOR), Cortés, Javier^1,2,3 (AUTHOR), Ruiz-Borrego, Manuel⁴ (AUTHOR), Colleoni, Marco⁵ (AUTHOR), Stradella, Agostina⁶ (AUTHOR), Bermejo, Begoña^7,8,9 (AUTHOR), Dalenc, Florence¹⁰ (AUTHOR), Escrivá-de-Romaní, Santiago¹¹ (AUTHOR), Calvo Martínez, Lourdes¹² (AUTHOR), Ribelles, Nuria¹³ (AUTHOR), Marmé, Frederik¹⁴ (AUTHOR), Cortés, Alfonso¹⁵ (AUTHOR), Albacar, Cinta¹⁶ (AUTHOR), Gebhart, Geraldine¹⁷ (AUTHOR), Prat, Aleix^18,19,20 (AUTHOR), Kerrou, Khaldoun^21,22 (AUTHOR), Schmid, Peter^23,24 (AUTHOR), Braga, Sofia^25,26 (AUTHOR), Di Cosimo, Serena²⁷ (AUTHOR), Gion, Maria¹⁵ (AUTHOR)

Superior Title: Lancet. 4/27/2024, Vol. 403 Issue 10437, p1649-1659. 11p.

Subject Terms: HORMONE receptor positive breast cancer, HER2 positive breast cancer, EPIDERMAL growth factor receptors, PROGRESSION-free survival

Company/Entity: F. Hoffmann-La Roche Ltd.

Zugang prüfen (DOI)

11

Academic Journal

Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial).

Authors: Kuo, Sung-Hsin^1,2,3,4 (AUTHOR), Tseng, Ling-Ming⁵ (AUTHOR), Chen, Shou-Tung⁶ (AUTHOR), Sagara, Yasuaki⁷ (AUTHOR), Chang, Yuan-Ching⁸ (AUTHOR), Yeh, Hsien-Tang⁹ (AUTHOR), Kuo, Yao-Lung¹⁰ (AUTHOR), Hung, Chih-Chiang¹¹ (AUTHOR), Lu, Tzu-Pin¹² (AUTHOR), Lee, Yi-Hsuan¹³ (AUTHOR), Toi, Masakazu¹⁴ (AUTHOR), Huang, Chiun-Sheng¹⁵ (AUTHOR) huangcs@ntu.edu.tw

Superior Title: BMC Cancer. 9/14/2023, Vol. 23 Issue 1, p1-10. 10p.

Subject Terms: *HORMONE receptor positive breast cancer, *RADIOTHERAPY, *LUMPECTOMY, *DUCTAL carcinoma, *CARCINOMA in situ, *TAMOXIFEN, *ESTROGEN, *DISEASE relapse

Geographic Terms: TAIWAN

HTML Full Text PDF Full Text

12

Academic Journal

Effects of Chronic Roundup Exposure on Medaka Larvae.

Authors: Killian, Deborah¹ (AUTHOR) wangxuegeng@scnu.edu.cn, Faheem, Mehwish^1,2 (AUTHOR), Reh, Beh¹ (AUTHOR), Wang, Xuegeng^1,3 (AUTHOR), Bhandari, Ramji Kumar^1,2 (AUTHOR) bhandarir@missouri.edu

Superior Title: Journal of Xenobiotics. Sep2023, Vol. 13 Issue 3, p500-508. 9p.

Subject Terms: *GLYPHOSATE, *THYROID hormone receptors, *LARVAE, *HERBICIDES, *ORYZIAS latipes, *ENDOCRINE glands, *ENDOCRINE system

HTML Full Text PDF Full Text

13

Academic Journal

Survey of clinicians on the use of adjuvant therapy for premenopausal women with breast cancer.

Authors: Lee, Young-Won¹ (AUTHOR), Ahn, Sei-Hyun² (AUTHOR), Lee, Young-jin¹ (AUTHOR), Yoo, Tae-Kyung¹ (AUTHOR), Kim, Jisun¹ (AUTHOR), Chung, Il Yong¹ (AUTHOR), Kim, Hee Jeong¹ (AUTHOR), Ko, Beom Seok¹ (AUTHOR), Lee, Jong Won¹ (AUTHOR), Son, Byung Ho¹ (AUTHOR), Lee, Sae Byul¹ (AUTHOR) newstar153@hanmail.net

Superior Title: PLoS ONE. 8/17/2023, Vol. 18 Issue 8, p1-13. 13p.

Subject Terms: *CANCER patients, *HORMONE receptors, *MEDICAL personnel, *OLDER patients, *ADJUVANT chemotherapy, *HORMONE therapy, *ESTROGEN receptors, *EPIDERMAL growth factor receptors

Geographic Terms: FREE State (South Africa)

HTML Full Text PDF Full Text

14

Academic Journal

Potential value of ctDNA monitoring in metastatic HR + /HER2 − breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial.

Authors: Chiu, Joanne¹ (AUTHOR), Su, Fei² (AUTHOR), Joshi, Mukta³ (AUTHOR), Masuda, Norikazu⁴ (AUTHOR), Ishikawa, Takashi⁵ (AUTHOR), Aruga, Tomoyuki⁶ (AUTHOR), Zarate, Juan Pablo² (AUTHOR), Babbar, Naveen² (AUTHOR), Balbin, O. Alejandro³ (AUTHOR), Yap, Yoon-Sim⁷ (AUTHOR) gmsyapys@nus.edu.sg

Superior Title: BMC Medicine. 8/15/2023, Vol. 21 Issue 1, p1-13. 13p.

Subject Terms: *HORMONE receptor positive breast cancer, *CIRCULATING tumor DNA, *CELL-free DNA, *EPIDERMAL growth factor, *METASTATIC breast cancer, *BREAST cancer

HTML Full Text PDF Full Text

15

Academic Journal

AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer.

Authors: Zhou, Meng¹ (AUTHOR), Gan, Xing-li¹ (AUTHOR), Ren, Yue-xiang² (AUTHOR) 13787713435@163.com, Chen, Qian-xin¹ (AUTHOR), Yang, Yuan-zhong³ (AUTHOR), Weng, Zi-jin² (AUTHOR), Zhang, Xiao-fang² (AUTHOR), Guan, Jie-xia² (AUTHOR), Tang, Lu-ying² (AUTHOR) tangly@mail.sysu.edu.cn, Ren, Ze-fang¹ (AUTHOR) renzef@mail.sysu.edu.cn

Superior Title: BMC Cancer. 8/11/2023, Vol. 23 Issue 1, p1-11. 11p.

Subject Terms: *HORMONE receptor positive breast cancer, *PROGNOSIS, *BREAST cancer, *BREAST cancer prognosis, *CANCER patients, *REFERENCE values

HTML Full Text PDF Full Text

16

Academic Journal

MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study.

Authors: van der Voort, Anna¹ (AUTHOR), Louis, Fleur M¹ (AUTHOR), van Ramshorst, Mette S¹ (AUTHOR), Kessels, Rob² (AUTHOR), Mandjes, Ingrid A² (AUTHOR), Kemper, Inge¹ (AUTHOR), Agterof, Mariette J³ (AUTHOR), van der Steeg, Wim A⁴ (AUTHOR), Heijns, Joan B⁵ (AUTHOR), van Bekkum, Marlies L⁶ (AUTHOR), Siemerink, Ester J⁷ (AUTHOR), Kuijer, Philomeen M⁸ (AUTHOR), Scholten, Astrid⁹ (AUTHOR), Wesseling, Jelle^10,11 (AUTHOR), Vrancken Peeters, Marie-Jeanne T F D^12,13 (AUTHOR), Mann, Ritse M^14,15 (AUTHOR), Sonke, Gabe S^1,16 (AUTHOR) g.sonke@nki.nl

Superior Title: Lancet Oncology. May2024, Vol. 25 Issue 5, p603-613. 11p.

Subject Terms: *HORMONE receptor positive breast cancer, *HER2 positive breast cancer, *NEOADJUVANT chemotherapy, *BODY surface area, *HORMONE receptors, *COMBINATION drug therapy

Geographic Terms: NETHERLANDS

Zugang prüfen (DOI)

17

Academic Journal

Variation Analysis in Premenopausal and Postmenopausal Breast Cancer Cases.

Authors: Erdogdu, Ibrahim Halil¹ (AUTHOR) ibrahim.halil.erdogdu@adu.edu.tr, Orenay-Boyacioglu, Seda² (AUTHOR) sorenay@adu.edu.tr, Boyacioglu, Olcay³ (AUTHOR) oboyaci@adu.edu.tr, Gurel, Duygu⁴ (AUTHOR) duygu.gurel@deu.edu.tr, Akdeniz, Nurten⁵ (AUTHOR) nakdeniz21@gmail.com, Meteoglu, Ibrahim¹ (AUTHOR) imeteoglu@adu.edu.tr

Superior Title: Journal of Personalized Medicine. Apr2024, Vol. 14 Issue 4, p434. 15p.

Subject Terms: *BREAST cancer, *HORMONE receptor positive breast cancer, *BREAST cancer prognosis, *HORMONE receptors, *SOMATIC mutation, *CHECKPOINT kinase 2

Geographic Terms: TURKEY

Zugang prüfen (DOI)

18

Academic Journal

Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies.

Authors: Tommasi, Chiara^1,2,3 (AUTHOR) chiara.tommasi@unipr.it, Airò, Giulia^1,2,3 (AUTHOR) fabiana.prattico@unipr.it, Pratticò, Fabiana^1,2,3 (AUTHOR) irene.testi@unipr.it, Testi, Irene^1,2 (AUTHOR) matilde.coriano@unipr.it, Corianò, Matilde^1,2,3 (AUTHOR) benedetta.pellegrino@unipr.it, Pellegrino, Benedetta^1,3 (AUTHOR), Denaro, Nerina⁴ (AUTHOR), Demurtas, Laura⁵ (AUTHOR) czsolinas@gmail.com, Dessì, Mariele⁵ (AUTHOR), Murgia, Sara⁶ (AUTHOR), Mura, Giovanni⁷ (AUTHOR), Wekking, Demi⁸ (AUTHOR), Scartozzi, Mario^5,6 (AUTHOR), Musolino, Antonino^1,2,3 (AUTHOR) chiara.tommasi@unipr.it, Solinas, Cinzia⁵ (AUTHOR)

Superior Title: Journal of Clinical Medicine. Apr2024, Vol. 13 Issue 7, p1873. 20p.

Subject Terms: *CANCER hormone therapy, *HORMONE receptor positive breast cancer, *BREAST cancer, *PROGESTERONE receptors, *HORMONE receptors

Zugang prüfen (DOI)

19

Academic Journal

Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective.

Authors: Coughlan, Diarmuid¹ (AUTHOR) diarmuid.coughlan@newcastle.ac.uk, Arisa, Oluwatomi² (AUTHOR), Thomson, Katie² (AUTHOR), Yu, Ge¹ (AUTHOR), Pearson, Fiona² (AUTHOR), Kernohan, Ashleigh¹ (AUTHOR), Gonzalez-Moral, Sonia Garcia² (AUTHOR), Wallace, Sheila² (AUTHOR), Rice, Stephen¹ (AUTHOR)

Superior Title: PharmacoEconomics. Jan2024, Vol. 42 Issue 1, p5-9. 5p.

Subject Terms: TRASTUZUMAB, HORMONE receptor positive breast cancer, EPIDERMAL growth factor receptors

Zugang prüfen (DOI)

20

Academic Journal

Pyrotinib in combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-positive metastatic breast cancer (PLEHERM): a multicenter, single-arm, phase II trial.

Authors: Hu, Zhe-Yu^1,2 (AUTHOR), Yan, Min³ (AUTHOR), Xiong, Huihua⁴ (AUTHOR), Ran, Li⁵ (AUTHOR), Zhong, Jincai⁶ (AUTHOR), Luo, Ting⁷ (AUTHOR), Sun, Tao⁸ (AUTHOR), Xie, Ning^1,2 (AUTHOR), Liu, Liping^1,2 (AUTHOR), Yang, Xiaohong^1,2 (AUTHOR), Xiao, Huawu^1,2 (AUTHOR), Li, Jing^1,2 (AUTHOR), Liu, Binliang^1,2 (AUTHOR), Ouyang, Quchang^1,2 (AUTHOR) oyqc1969@126.com

Superior Title: BMC Medicine. 6/26/2023, Vol. 21 Issue 1, p1-10. 10p.

Subject Terms: *HORMONE receptor positive breast cancer, *EPIDERMAL growth factor receptors, *METASTATIC breast cancer, *HER2 positive breast cancer, *LETROZOLE, *TERMINATION of treatment

HTML Full Text PDF Full Text

Narrow Search